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a b s t r a c t
Intramedullary arteriovenous malformations (AVMs) in the cervical region are a rare clinical
condition. They represent a therapeutic challenge, as the lesions may cause serious func-
tional disorders due to their location within or immediately adjacent to the critical ascend-
ing and descending sensorimotor pathways. In this case report, we present a patient with a
cervical intramedullary AVM that was treated with endovascular therapy. Our experience
suggests that endovascular treatment is an effective and safe method for treating AVMs
located in the cervical region of the spinal cord. More studies are needed to establish
appropriate treatment protocols depending on the clinical course, the anatomy of the
lesion, and the region in which it is found.
# 2014 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All
rights reserved.
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Spinal arteriovenous malformations (AVMs) are rare clinical
entities that can lead to myelopathy, progressive neurological
symptoms, and even death if not properly treated [1,2].
Symptomatic spinal AVMs are generally thought to require
treatment [3].
Two AVM treatment modalities are available: surgery and
endovascular therapy. Endovascular occlusion is considered to* Corresponding author at: First Department of Neurology, Institute of
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E-mail addresses: aacewicz@ipin.edu.pl, a.acewicz@gmail.com (A. 
http://dx.doi.org/10.1016/j.pjnns.2014.04.002
0028-3843/# 2014 Polish Neurological Society. Published by Elsevier Ube the ﬁrst-line treatment for most spinal vascular malforma-
tions [2–6], because surgical obliteration is accompanied by a
high level of intraprocedural risk, especially if the lesion lies on
or within the ventral portion of the spinal cord [4–7].
Intramedullary AVMs in the cervical spinal cord require
special attention; they occur more rarely than AVMs in other
regions of the spinal cord [8] and can be dangerous, due to their
location within or immediately adjacent to critical ascending
and descending sensorimotor pathways. The clinical presen-
tation, course, and results of endovascular treatment of Psychiatry and Neurology, Sobieskiego 9, 02-957 Warsaw, Poland.
Acewicz).
rban & Partner Sp. z o.o. All rights reserved.
Fig. 1 – Sagittal T2-weighted MR image showing
intramedullary spinal AVM at the level of C5. Extension of
the spinal cord C3–C7 and edema extending to the medulla
oblongata are visible.
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Here, we present a patient with a cervical intramedullary AVM
that was treated with endovascular therapy.
2. Case report
A 17-year old girl suddenly experienced neck pain radiating to
her right upper limb, weakness of the right upper limb, and
right-sided paresthesia that progressed over several weeks.Fig. 2 – Right vertebral angiography (side and anteroposterior) sho
arterial branches from the right vertebral artery (A, B). Frontal an
within the AVM nidus filling from the left side from one branchSimilar symptoms had occurred 2 years earlier: sudden pain
and paresthesia of the right upper limb that resolved
spontaneously within a month. In addition, the patient had
been under the care of endocrine and orthopedic specialists for
several years, because of growth deﬁciency and curvature of
the spine, respectively. A neurological examination at admis-
sion revealed right-sided hyperesthesia, muscle weakness in
the right hand (4/5 strength), and neck pain upon palpation.
Brain magnetic resonance imaging (MRI) was normal. MRI of
the cervical spine demonstrated a centrally located, predomi-
nantly on the ventral side lesion 10 mm in diameter at the level
of C5, which suggested hemorrhage or aneurysm. Anterior to
the lesion, we observed a network of small vessels associated
with the AVM, which were surrounded by edema. Adminis-
tration of contrast agent revealed small, punctate enhance-
ment lesions within the AVM (Fig. 1). Digital subtraction
angiography was performed to deﬁne the type of vascular
malformation and consequently decide upon the appropriate
therapy.
Digital subtraction angiography was performed under local
anesthesia. After transfemoral access and sheath placement,
the patient received 3000 units of intravenous heparin.
Bilateral vertebral angiography showed a glomus-type intra-
medullary AVM supplied by the arterial branches from the left
and right vertebral arteries. Within the AVM nidus, we
observed a large aneurysm that was ﬁlling from the left side
(Fig. 2). The lesion was believed to carry an extremely high
surgical risk given its location; therefore, we decided to
perform endovascular treatment.
The ﬁrst therapeutic goal was to exclude the nidal
aneurysm from circulation to prevent possible bleeding. After
the diagnostic angiography, a 6-F catheter was placed in the
left vertebral artery. A 1.5-F ﬂow-guide microcatheter (Magic;
Balt Extrusion, Montmorency, France) was subsequently
navigated over a 0.00700 microwire (Sorceror; Balt Extrusion)wing the nidus of the glomus-type AVM supplied by the two
giogram of the left vertebral artery showing aneurysm
 of the left vertebral artery (C).
Fig. 3 – Frontal angiogram of the left vertebral artery demonstrating the position of the microcatheter prior to NBCA injection
(A). Left vertebral artery angiogram following NBCA injection. Contrast material did not enter the nidus from the left side (B).
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and supplying the AVM and aneurysm. We decided to
embolize the feeding arteries rather than the AVM to prevent
distal migration of embolic material into the veins of the
AVM and the spinal cord as much as possible. Blood ﬂow to
the AVM from the left vertebral artery was prevented with a
25% mixture of N-butyl cyanoacrylate (NBCA; B. Braun,
Aesculap AG, Tuttlingen, Germany) in Lipiodol (Guerbet AG,
Zurich, Switzerland) under ﬂuoroscopic control (Fig. 3). No
complications occurred. After the procedure, we observed
clinical improvement; the patient's pain had disappeared,
and the mobility of her right upper limb had improved.
However, the patient still reported paresthesia of the right
upper limb. After several days, the patient was discharged
home and the next stage of the procedure was scheduled for
1 month later.
During the follow-up hospitalization, we performed right
vertebral angiography, which showed a residual cervical AVM
fed by two arterial branches from the right vertebral artery.
Both supplying vessels were embolized with NBCA, which
almost completely excluded the AVM from circulation;
residual blood ﬂow into the AVM was observed (Fig. 4). No
complications occurred, and the patient's general and neuro-
logical condition was the same as before the procedure. MRI
revealed that there was a reduction in the blood vessel
network and less edema. We discharged the patient home and
scheduled a follow-up angiography for 8 months later.3. Discussion
Data from spinal angiography, clinical evaluations, and
surgical explorations have revealed that spinal AVMs are a
relatively heterogeneous group of vascular lesions, and that
each type requires a different management paradigm. The
most widely used classiﬁcation for AVM is based on both the
location and the vascular characteristics; four types of AVM
are described [2,3]. In our patient, the AVM was relatively small
in size (10 mm) and characterized by a compact intramedul-
lary nidus interposed between multiple feeding arteries and
their respective draining veins, with angioarchitecture similar
to that of brain AVMs. These characteristics, along with the
young age of the patient, are consistent with those of Type II
(glomus) AVM. Rather than a slow, progressive neurological
decline, glomus-type AVMs typically lead to sudden deterio-
ration secondary to rupture of the nidal aneurysm [3].
Endovascular occlusion is considered to be the ﬁrst-line
treatment for most spinal vascular malformations [2–6]. The
morphological target (i.e., partial or complete obliteration of
the AVM), the sequence of sessions used, the therapeutic
goals, and the technique used should be chosen after careful
analysis of the patient's history and neurological status with
correlation to the angioarchitectural features of the AVM. If
complete obliteration is not possible, partial targeted emboli-
zation should be performed, with the aim of neutralizing
Fig. 4 – Right frontal vertebral angiogram demonstrating residual AVM fed by two arterial branches from the right vertebral
artery (A). Right frontal vertebral angiogram after NBCA injection showing almost complete exclusion of the AVM from
circulation (B).
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contrast to brain AVM, in most cases partial treatment of
cervical AVM appears to be sufﬁcient to dramatically improve
the prognosis [9].
Endovascular therapy has traditionally been performed with
particulate agents such as polyvinyl alcohol (PVA) and liquid
adhesives such as NBCA. We used NBCA in our patient. This may
be the best therapeutic option for embolization of spinal AVMs in
regions where special caution is required. The use of this liquid
embolic agent is clearly established in the literature and in
clinical practice, and it is associated with good anatomical and
clinical results. In most cases, there is improvement or
stabilization of patient clinical status and protection from
hemorrhagic events with good long-term effects, a low rate of
operative morbidity, a reduction in the number of therapeutic
sessions, and a low rate of recanalizations [7,10]. However,
acrylic glue should be used only by experienced teams,
particularly for spinal AVMs in dangerous regions like the
cervical region, since it requires considerable skill to prevent
inadvertent proximal reﬂux of the embolic material, excessive
premature venous penetration, and gluing of the catheter within
the vascular pedicle during slow injections.
There is a growing body of evidence regarding the
successful use of Onyx to treat spinal AVMs endovascularly
[9,11,12]. As an alternative liquid embolic agent, Onyx appears
to have several advantages: it can be delivered at asigniﬁcantly slower injection speed over several minutes,
and there is a lower risk of premature occlusion of the venous
side and a reduced possibility of gluing the catheter [9].
However, limitations remain with regard to technique and
iatrogenic episodes associated with the delivery of Onyx in
small perimedullary veins involved in drainage in the normal
spinal cord. Although Onyx has been used many times in the
treatment of brain AVMs [13], there is a need for more studies
on the use of Onyx in the embolization of spinal AVMs.
Glomus AVMs in cervical regions represent a therapeutic
challenge, as the lesions may cause serious functional disorders
due to their location within or immediately adjacent to critical
ascending and descending sensorimotor pathways. To the best
of our knowledge, relatively few cases in the literature have
described embolization of spinal intramedullary AVMs in the
cervical region; they have mostly been reported as part of larger
series of cases [9,11,12,14]. However, these studies did report that
endovascular treatment of AVMs in the cervical region seems to
be effective and safe (no change or transitory worsening in
immediate outcome, with improvement upon clinical follow-up
after a few months), few details about these patients, the
procedures, and the clinical courses have been reported. More-
detailed series and cases need to be described before appropriate
and precise guidelines for treatment can be set forth.
In conclusion, we present a patient with a glomus-type
intramedullary AVM in the cervical region of the spinal cord
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to be an effective and safe method for the treatment of lesions
located in this region of the spinal cord; however, this method
requires considerable experience and caution. More studies are
needed to help establish appropriate algorithms of treatment
depending upon the clinical course, the anatomy of the lesion,
and the region in which the AVM occurs.
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